Shailaja Srinagesh

Title: Shailaja Srinagesh: Innovator in Antibody Drug Conjugates

Introduction

Shailaja Srinagesh is a prominent inventor based in San Mateo, CA (US). She has made significant contributions to the field of biotechnology, particularly in the development of antibody drug conjugates. With a total of 3 patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

One of her latest patents focuses on anti-CD70 antibody drug conjugates. This invention relates to anti-CD70 antibodies and antibody drug conjugates that comprise at least one non-naturally-encoded amino acid. The patent discloses αCD70 antibodies with one or more non-naturally encoded amino acids. Furthermore, it details antibody drug conjugates wherein the αCD70 antibodies are conjugated to one or more toxins. The methods for using such non-natural amino acid antibody drug conjugates include therapeutic, diagnostic, and other biotechnology applications.

Career Highlights

Shailaja Srinagesh is currently associated with Ambrx, Inc., where she continues to advance her research in antibody drug conjugates. Her innovative work has garnered attention in the biotechnology community, contributing to the development of new therapeutic strategies.

Collaborations

She collaborates with notable colleagues, including Richard Spence Barnett and Ying Sun, who contribute to her research endeavors.

Conclusion

Shailaja Srinagesh's contributions to the field of biotechnology, particularly in antibody drug conjugates, highlight her role as an influential inventor. Her work continues to inspire advancements in therapeutic applications.